
EMMA
Healthcare · Biotechnology · $1.6M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2024
EPS trend, 90 days to now · -100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 20, 2025 | Time not confirmed | — | -0.03 | — |
| Sep 8, 2025 | Before the open | — | -0.02 | — |
| Apr 14, 2025 | Time not confirmed | 0.01 | -0.03 | -400.0% |
| Nov 12, 2024 | Before the open | 0.01 | 0.01 | +12.0% |
| Jul 3, 2024 | Before the open | 0.01 | -0.01 | -200.0% |
| Apr 30, 2024 | Before the open | 0.01 | -0.01 | -200.0% |
| Mar 29, 2024 | Time not confirmed | — | 0.02 | — |
| Nov 14, 2023 | Before the open | -0.04 | -0.01 | +75.0% |
| Aug 14, 2023 | After the close | -0.03 | -0.03 | 0.0% |
| May 15, 2023 | Before the open | -0.03 | 0.00 | +113.3% |
| Mar 31, 2023 | After the close | 0.16 | 0.01 | -93.8% |
| Nov 14, 2022 | After the close | 0.01 | -0.01 | -200.0% |
| Aug 15, 2022 | After the close | 0.01 | -0.18 |
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients five years of age and older. It has…
| -1900.0% |
| May 13, 2022 | Before the open | 0.01 | -0.03 | -400.0% |
| Mar 31, 2022 | After the close | 0.05 | 0.05 | 0.0% |
| Nov 12, 2021 | After the close | -0.06 | -0.57 | -850.0% |
| Sep 2, 2021 | After the close | -0.06 | -0.57 | -850.0% |
| May 4, 2021 | Before the open | -0.78 | -0.01 | +98.7% |
| Jan 25, 2021 | Before the open | -1.56 | -1.30 | +16.7% |
| Dec 2, 2020 | Time not confirmed | -0.78 | 0.11 | +114.1% |
| Aug 11, 2020 | Time not confirmed | -0.66 | -0.19 | +71.2% |
| May 20, 2020 | Time not confirmed | -0.66 | 0.11 | +116.7% |
| Mar 31, 2020 | Time not confirmed | — | 0.11 | — |
| Nov 12, 2019 | Before the open | -1.38 | -0.60 | +56.5% |
| Aug 14, 2019 | After the close | -1.56 | -1.20 | +23.1% |
| May 13, 2019 | Before the open | -1.56 | -1.62 | -3.8% |
| Feb 14, 2019 | After the close | -1.56 | -1.92 | -23.1% |
| Dec 11, 2018 | After the close | -2.24 | -1.20 | +46.4% |
| Aug 10, 2018 | After the close | -2.64 | -2.76 | -4.5% |
| May 14, 2018 | After the close | -1.74 | -3.66 | -110.3% |
| Feb 20, 2018 | After the close | -1.68 | -3.84 | -128.6% |